185 related articles for article (PubMed ID: 21480333)
1. Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis.
Zhang D; Utsumi T; Huang HC; Gao L; Sangwung P; Chung C; Shibao K; Okamoto K; Yamaguchi K; Groszmann RJ; Jozsef L; Hao Z; Sessa WC; Iwakiri Y
Hepatology; 2011 Apr; 53(4):1306-15. PubMed ID: 21480333
[TBL] [Abstract][Full Text] [Related]
2. Absence of Nogo-B (reticulon 4B) facilitates hepatic stellate cell apoptosis and diminishes hepatic fibrosis in mice.
Tashiro K; Satoh A; Utsumi T; Chung C; Iwakiri Y
Am J Pathol; 2013 Mar; 182(3):786-95. PubMed ID: 23313137
[TBL] [Abstract][Full Text] [Related]
3. Reticulon 4B (Nogo-B) facilitates hepatocyte proliferation and liver regeneration in mice.
Gao L; Utsumi T; Tashiro K; Liu B; Zhang D; Swenson ES; Iwakiri Y
Hepatology; 2013 May; 57(5):1992-2003. PubMed ID: 23299899
[TBL] [Abstract][Full Text] [Related]
4. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
[TBL] [Abstract][Full Text] [Related]
5. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
[TBL] [Abstract][Full Text] [Related]
6. Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
Klein S; Rick J; Lehmann J; Schierwagen R; Schierwagen IG; Verbeke L; Hittatiya K; Uschner FE; Manekeller S; Strassburg CP; Wagner KU; Sayeski PP; Wolf D; Laleman W; Sauerbruch T; Trebicka J
Gut; 2017 Jan; 66(1):145-155. PubMed ID: 26385087
[TBL] [Abstract][Full Text] [Related]
7. Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.
Lei XF; Fu W; Kim-Kaneyama JR; Omoto T; Miyazaki T; Li B; Miyazaki A
J Hepatol; 2016 Jan; 64(1):110-7. PubMed ID: 26334580
[TBL] [Abstract][Full Text] [Related]
8. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
9. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
10. Endothelial nitric oxide synthase is not essential for the development of fibrosis and portal hypertension in bile duct ligated mice.
Koshy A; De Gottardi A; Ledermann M; Saegesser H; Shaw SG; Zimmermann A; Reichen J
Liver Int; 2005 Oct; 25(5):1044-52. PubMed ID: 16162165
[TBL] [Abstract][Full Text] [Related]
11. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis.
De Minicis S; Seki E; Paik YH; Osterreicher CH; Kodama Y; Kluwe J; Torozzi L; Miyai K; Benedetti A; Schwabe RF; Brenner DA
Hepatology; 2010 Oct; 52(4):1420-30. PubMed ID: 20690191
[TBL] [Abstract][Full Text] [Related]
12. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.
Olsen AL; Sackey BK; Marcinkiewicz C; Boettiger D; Wells RG
Gastroenterology; 2012 Apr; 142(4):928-937.e3. PubMed ID: 22202457
[TBL] [Abstract][Full Text] [Related]
13. Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cells.
Chen YH; Lan T; Li J; Qiu CH; Wu T; Gou HJ; Lu MQ
World J Gastroenterol; 2012 Dec; 18(48):7158-65. PubMed ID: 23326120
[TBL] [Abstract][Full Text] [Related]
14. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
Li Y; Lua I; French SW; Asahina K
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
[TBL] [Abstract][Full Text] [Related]
15. Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient Kit
Hargrove L; Kennedy L; Demieville J; Jones H; Meng F; DeMorrow S; Karstens W; Madeka T; Greene J; Francis H
Hepatology; 2017 Jun; 65(6):1991-2004. PubMed ID: 28120369
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis.
Kim SE; Park JW; Kim MJ; Jang B; Jeon YC; Kim HJ; Ishigami A; Kim HS; Suk KT; Kim DJ; Park CK; Choi EK; Jang MK
PLoS One; 2018; 13(8):e0201744. PubMed ID: 30071078
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.
Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H
J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751
[TBL] [Abstract][Full Text] [Related]
18. Hepatic stellate cells (Ito cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat.
Zimmermann H; Fellay M; Zimmermann A
J Hepatol; 1997 Jan; 26(1):158-66. PubMed ID: 9148007
[TBL] [Abstract][Full Text] [Related]
19. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.
Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH
BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
